Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Bayer describes new ASA derivatives

Dec. 19, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Sandoz reports on tetraline derivatives for neurological disorders

Dec. 18, 1996

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.